Mediators of Inflammation / 2015 / Article / Tab 5

Research Article

Expression of Chemokine Receptors on Peripheral Blood T Cells in Children with Chronic Kidney Disease

Table 5

Percentage values of T cell subpopulations, including populations with expression of receptors for selected chemokines in children on maintenance hemodialysis.

Lymphocyte subpopulations %]Before HD HD 15 minAfter HD

T lymphocytes 71,0 (53,4–90,1)73,3 (64,3–99,3)74,5 (30,4–90,1)0,4431
CD4+ T cells41,8 (15,2–55,5)39,1 (8,4–60,1)46,7 (31,0–66,2)0,0211
CD8+ T cells31,2 (13,5–45,0)21,2 (10,7–44,0)25,4 (13,1–76,5)0,3521
CCR7+ T cells15,4 (2,1–33,7)19,4 (2,2–49,0)14,6 (2,9–42)0,6822
CD45RO+CCR7+2,4 (0,4–10,1)3,2 (0,5–8.3)2,0 (0,5–6,0)0,6933
CD28+CCR7+ T cells15,1 (2,1–32,4)19,1 (2,2–48,5)14,6 (2,4–41,5)0,6777
CXCR4+ T cells10,6 (1,3–45,9)15,3 (4,7–37,8)8,4 (1,2–42,2)0,8561
CXCR4+ CD4+ T cells2,6 (0,001–31,7)6,8 (0,8–13,2)2,1 (0,001–29,1)0,7951
CXCR4+ CD8+ T cells6,7 (1,3–21,3)6,8 (2,7–34,0)5,8 (1,2–15,0)0,5598
CXCR4+CCR5+ T cells0,8 (0,001–8,5)1,1 (0,002–12,9)0,5 (0,001–3,2)0,3834
CCR5+ T cells13,0 (3,6–26,9)12,2 (4,8–32,4)9,3 (2,4–21,1)0,0954
CCR5+CD4+ T cells3,2 (1,3–5,6)3,3 (2,1–7,8)2,4 (0,4–8,3)0,4225
CCR5+CD8+ T cells7,4 (1,7–21,7)6,3 (2,1–27,2)3,9 (1,5–15,3)0,3314
CCR4+ T cells5,0 (0,3–22,3)5,2 (0,6–23,2)7,6 (0,5–17,3)0,9458
CCR4+ CD4+ T cells4,4 (0,9–47,3)4,0 (1,2–9,6)4,1 (1,2–11,5)0,4381
CCR4+ CD8+ T cells2,0 (0,002–14,2)1,5 (0,3–19,8)1,9 (0,001–13,9)0,9607
CXCR3+ T cells31,8 (14,8–42,7)35,4 (24,9–43,6)29,5 (3,2–39,9)0,0294
CXCR3+CD4+ T cells10,7 (4,9–18,1)12,7 (8,5–18,2)11,5 (0,8–49,2)0,5741
CXCR3+CD8+ T cells14,4 (8,5–33,2)18,5 (9,7–30,8)14,2 (2,0–20,7)0,1801
CXCR3+CCR5+ T cells10,6 (3,1–23,4)9,9 (3,7–22,4)6,9 (1,6–22,7)0,0892
CXCR3+CXCR4+ T cells7,4 (0,7–20,3)6,5 (3,1–23,7)4,3 (0,8–18,0)0,6788

Percentage values are shown as median value (minimum–maximum).
: significance in ANOVA test.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.